These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12162433)

  • 1. Effects of antioxidants against atherosclerosis.
    Niki E; Noguchi N
    Mol Cell Biochem; 2002; 234-235(1-2):19-25. PubMed ID: 12162433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antioxidants, oxidation of LDL and atherosclerosis].
    Salonen JT; Kovanen PT; Ylä-Herttuala S; Korpela H
    Duodecim; 1991; 107(15):1232-9. PubMed ID: 1365345
    [No Abstract]   [Full Text] [Related]  

  • 3. Still life in oxidation hypothesis of atherogenesis.
    Durrington PN; Mackness MI
    Lancet; 2000 Jul; 356(9224):165. PubMed ID: 10963272
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of oxidized lipoproteins in atherogenesis.
    Berliner JA; Heinecke JW
    Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized LDL, atherogenesis and antioxidants.
    Waickus CM
    Am Fam Physician; 1993 Oct; 48(5):718-20. PubMed ID: 8213399
    [No Abstract]   [Full Text] [Related]  

  • 6. Antioxidants and atherosclerosis.
    Niki E
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):156-9. PubMed ID: 14748738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
    Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
    Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidative modifications in atherosclerosis.
    Stocker R; Keaney JF
    Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of oxidized lipoproteins for the development of atherosclerosis. Antioxidants as a therapeutic alternative in atherosclerosis].
    Boberg KM
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1861-5. PubMed ID: 1853321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
    Matthews AJ; Vercellotti GM; Menchaca HJ; Bloch PH; Michalek VN; Marker PH; Murar J; Buchwald H
    J Surg Res; 1997 Nov; 73(1):35-40. PubMed ID: 9441790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidants and antioxidants in atherosclerosis.
    Mashima R; Witting PK; Stocker R
    Curr Opin Lipidol; 2001 Aug; 12(4):411-8. PubMed ID: 11507326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of atherosclerosis. The potential role of antioxidants.
    Mehra MR; Lavie CJ; Ventura HO; Milani RV
    Postgrad Med; 1995 Jul; 98(1):175-6, 179-84. PubMed ID: 7603945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase.
    da Silva EL; Abdalla DS; Terao J
    IUBMB Life; 2000 Apr; 49(4):289-95. PubMed ID: 10995031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis.
    Noguchi N; Niki E
    Free Radic Biol Med; 2000 May; 28(10):1538-46. PubMed ID: 10927179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidants and antioxidants in atherogenesis. An appraisal.
    Parthasarathy S; Santanam N; Ramachandran S; Meilhac O
    J Lipid Res; 1999 Dec; 40(12):2143-57. PubMed ID: 10588940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low density lipoprotein oxidation, antioxidants, and atherosclerosis.
    Catapano AL; Maggi FM; Tragni E
    Curr Opin Cardiol; 2000 Sep; 15(5):355-63. PubMed ID: 11128189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.